Company Search:
Advanced Search
Sponsored Links
Vivus, Inc. Company Snapshot
Vivus, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vivus with three other companies in this sector in the United States: MacroGenics Inc (2015 sales of $100.85 million of which 100% was Biopharmaceuticals), Merrimack Pharmaceuticals Inc ($89.26 million of which 100% was Pharmaceutical Preparations), and ImmunoGen, Inc. ($85.54 million of which 100% was Cancer Therapeutics).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vivus, Inc.
  Stock Performance Chart for Vivus, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 1.20
(Figures in U.S. Dollars)
1 Week -4.0%   13 Weeks -14.3%  
4 Weeks 13.2%   52 Weeks 15.4%  
Vivus, Inc. Key Data:
  Ticker: VVUS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 95,430,000
(Year Ending Jan 2016).
Employees: 121
  Currency: U.S. Dollars Market Cap: 125,811,961
  Fiscal Yr Ends: December Shares Outstanding: 104,843,301
  Share Type: Common Closely Held Shares: 6,207,815
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.